Saroja Pharma Industries India Limited — Board Meeting, 22-08-2026: Outcome of Board Meeting
22-08-2026 | 03:36 pm
22-08-2026 | 03:36 pm
SAROJA PHARMA's board approved key management changes. Mr. Pulinattu Damodaran Nandakumar is re-designated as Whole-time Director. The board also appointed Mr. Niraj Variava, a Chartered Accountant, as Internal Auditor for FY2026-27.
No comments yet. Be the first to comment!
All announcements from Saroja Pharma Industries India Limited
